In MCF-7 breast carcinoma xenografts, compound 3a (25 mg/kg every second day for 6 days, i.p.)inhibited tumor growth associated with induction of p21 and suppression of FoxM1 and survivin. Here, FOXM1 is linked to breast carcinoma.